New York, US–July 01, 2019Recently, Creative Biolabs, a powerful biotechnology company located in New York, claimed that it can provide the most comprehensive recombinant antibody products in the world. By constantly upgrading the library construction and screening processes, the company has acquired mature proprietary procedures for recombinant antibody manufacturing, capable of rapidly isolating clones with affinity up to the sub-nanomolar level. Meanwhile, therapeutic antibodies and single domain antibodies are its featured products, too.
Recombinant antibodies are made through recombinant DNA technology, which involves the inserting of a DNA fragment into bacterium, yeast, or mammalian cells. Thus far, they have been broadly applied in medical research as a therapy against certain specific targets. Moreover, they play a significant role in preparing pharmaceutical compounds to overcome a variety of diseases, such as cancer, HIV, and herpes simplex virus (HSV). All of these applications may as well be attributed to their many advantages.
“The advantages of recombinant antibodies include high purity and affinity, broad applications and excellent reproducibility. Besides, the experiment conditions are under complete control, with a rather short production time. Most importantly, recombinant antibodies can be produced in vitro, forsaking the use of animals. That’s why we appreciate recombinant antibodies so much. Through years of efforts in the field, we have become able to isolate clones quickly with affinity going up to the sub-nanomolar level. Simultaneously, we also make available bulk orders from 1mg to 10g,” stated a scientist in Creative Biolabs.
“By the way, we have also served a wide range of therapeutic antibodies for disease treatment. Our endotoxin-free antibodies are fully functional and ready to be used in animal-based assays. It’s worth mentioning that Creative Biolabs has the most complete collection of single domain antibodies products the world has ever had. Its proprietary platform allows rapid and large-scale production of high affinity novel biological therapeutics. In addition to these antibodies mentioned, our other marvelous engineering antibody products also include bispecific antibodies, antibody-drug conjugates (ADCs), immunotoxins, antibody-cytokine fusion proteins (ACFPs), and intrabodies.”
Indeed, given the considerable significance of recombinant antibodies, it’s of great value to offer such a platform that generates miscellaneous high-quality products to fulfill the market demand. With the optimization of engineering technology and the advancement of biological science, it can be assumed that in the coming future, engineered antibody products represented by recombinant antibodies will continue to solicit increasing attention from the industry and academia. In the meantime, superior platforms for antibody production will be in immense demand.
About Creative Biolabs
As a leader in recombinant antibody discovery and manufacturing, Creative Biolabs is committed to providing its global customers with the most comprehensive range of recombinant antibody products and extensive service portfolio at the most competitive price. Its products range from antibody/peptide libraries, biosimilar cell lines, chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies. It also provides a variety of custom antibody discovery and engineering services.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States